Kimberly-Clark
Maker of Huggies diapers, Kleenex tissues, Kotex feminine care, and Depend incontinence products.
Something off on this page? Send us feedback.
Profile
Manufactures diapers, training pants, feminine and incontinence care, household tissue, and workplace hygiene products under Huggies, Kotex, Depend, Kleenex, Scott, and other brands. North America generates most continuing sales, while consolidated international operations now center on personal care following the launch of the Arbex tissue and hygiene joint venture.
Manufactures diapers, training pants, feminine-care and incontinence products, household tissue, paper towels, and workplace hygiene supplies. Huggies, Pull-Ups, GoodNites, Kotex, Depend, Poise, Kleenex, Scott, Cottonelle, and WypAll reach households and institutional buyers through retailers, distributors, and e-commerce.
North America spans baby and child, adult, feminine, family, and professional care and generates most continuing sales; International Personal Care concentrates on the first three categories in selected markets. Manufacturing depends on cellulose fiber, synthetics, chemicals, and superabsorbent materials purchased from third parties. Following Arbex's launch, most international tissue and professional operations sit in a Suzano-controlled joint venture where a minority interest is retained. The pending Kenvue acquisition remains on track to close by year-end.
Company facts
Key statistics
Year to date +8.0% · Average volume (30d) 3.2M
Analysts
Ratings
Target range
Latest analyst notes
| Date | Firm | Action | Rating | Prior target | Target |
|---|---|---|---|---|---|
| Aug 5, 2026 | UBS | Reiterate | Neutral | $115 | $116 |
| Aug 4, 2026 | Seaport Global | Upgrade | Buy | ||
| Jul 21, 2026 | Barclays | Reiterate | Equal Weight | $99 | $115 |
| Jul 16, 2026 | UBS | Reiterate | Neutral | $106 | $115 |
| Jun 17, 2026 | Piper Sandler | Reiterate | Overweight | $145 | $121 |
Earnings
EPS
Revenue
History
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Next session |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026Q2 FY26 | $2.01 | $1.80 | −10.4% | $4.22B | $4.19B | −0.8% | +3.73% |
| Apr 28, 2026Q1 FY26 | $1.93 | $1.97 | +2.1% | $4.09B | $4.16B | +1.9% | −2.38% |
| Jan 27, 2026Q4 FY25 | $1.81 | $1.86 | +2.8% | $4.09B | $4.08B | −0.3% | −1.09% |
| Oct 30, 2025Q3 FY25 | $1.75 | $1.82 | +4.0% | $4.09B | $4.13B | +0.9% | −0.42% |
Financial highlights
| 12 quarters | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | |
|---|---|---|---|---|---|---|---|
| Revenue | $4.84B | $4.16B | $4.13B | $4.08B | $4.16B | $4.19B | |
| Gross profit | $1.73B | $1.46B | $1.48B | $1.47B | $1.53B | $1.60B | |
| Operating income | $769.0M | $592.0M | $621.0M | $507.0M | $475.0M | $448.0M | |
| Net income | $567.0M | $509.0M | $446.0M | $499.0M | $665.0M | $345.0M | |
| Diluted EPS | $1.70 | $1.53 | $1.34 | $1.50 | $2.00 | $1.04 | |
| Gross margin | 35.8% | 35.0% | 35.7% | 35.9% | 36.8% | 38.3% | |
| Operating margin | 15.9% | 14.2% | 15.0% | 12.4% | 11.4% | 10.7% |
Fiscal years (4-quarter sums)FY21 $19.44B · FY22 $20.18B · FY23 $20.43B · FY24 $18.45B · FY25 $17.22B
Revenue by product · Q2 FY26
Revenue by geography · FY25
Balance sheet, Jun 30, 2026Cash & short-term investments $956.0M · Total debt $6.52B · Total assets $18.55B · Shareholders' equity $1.75B
Dividends
Raised for 40 straight years — most recently to $1.28 from $1.26 in Mar 2026. To collect a payout, hold shares through the close before the ex-date.
History
| Ex-date | Record | Paid | Amount | Note |
|---|---|---|---|---|
| Jun 5, 2026 | Jun 5 | Jul 2 | $1.28 | |
| Mar 6, 2026 | Mar 6 | Apr 2 | $1.28 | raised from $1.26 |
| Dec 5, 2025 | Dec 5 | Jan 5 | $1.26 | |
| Sep 5, 2025 | Sep 5 | Oct 2 | $1.26 | |
| Jun 6, 2025 | Jun 6 | Jul 2 | $1.26 | |
| Mar 7, 2025 | Mar 7 | Apr 2 | $1.26 | raised from $1.22 |
| Dec 6, 2024 | Dec 6 | Jan 3 | $1.22 | |
| Sep 6, 2024 | Sep 6 | Oct 2 | $1.22 |
Ownership
A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.
Shares outstanding 331.94M · Float 331.22M · 99.8% free float
Top shareholders13F · 13D/G · Form 4
| Holder | Shares | % outstanding | Form | Filed |
|---|---|---|---|---|
| BlackRock, Inc. | 32.32M | 9.74% | 13F | Aug 7, 2026 |
| Vanguard Capital Management LLC | 21.66M | 6.53% | 13F | Aug 13, 2026 |
| State Street Corp | 21.08M | 6.35% | 13F | Aug 7, 2026 |
| Vanguard Portfolio Management LLC | 16.10M | 4.85% | 13F | Aug 13, 2026 |
| FMR LLC | 13.13M | 3.96% | 13F | Aug 13, 2026 |
Insider tradesForm 4
| Date | Insider | Role | Shares | Avg price |
|---|---|---|---|---|
| May 6, 2026 | Andrew Scribner | officer: Controller, VP & FP&A | −4,095 | $98.00 |
| May 4, 2026 | Katy Chen | officer: President, Int'l Personal Care | −1,596 | $95.34 |
| Apr 30, 2026 | Katy Chen | officer: President, Int'l Personal Care | −1,405 | $96.96 |
| Feb 9, 2026 | Todd Maclin | director | +10,000 | $104.15 |
| Apr 9, 2025 | Todd Maclin | director | +266 | $145.77 |
Peers
- Procter & Gamble
Dominant global rival across diapers, femcare, tissue, and adult incontinence.
- Haleon (ADR)
Global OTC consumer health leader competing on pain relief, oral care, and VMS.
CompareAfter-hours close
| Company | Price | Change | |||||
|---|---|---|---|---|---|---|---|
| Kimberly-Clark | $110.00 | +0.42% | $36.36B | 18.6 | 15.5 | 2.2 | +0.6% |
| Procter & Gamble | $143.75 | +0.01% | $341.75B | 21.7 | 20.5 | 3.9 | +1.5% |
| Haleon (ADR) | $10.11 | +0.05% | $44.52B | 20.7 | 10.8 | 2.9 | +3.7% |
| Median | 21.2 | 15.7 | 3.4 | +2.6% |